Sutro Biopharma Inc. News

Latest updates and market news for STRO

7 news

Mar 23 - Mar 29, 2026

Page 1

MT Newswires

4 days ago

Deutsche Bank Adjusts Sutro Biopharma Price Target to $55 From $51, Maintains Buy Rating

MT Newswires

5 days ago

Wells Fargo Upgrades Sutro Biopharma to Overweight From Equal Weight, Adjusts PT to $27 From $8

MT Newswires

5 days ago

HC Wainwright Upgrades Sutro Biopharma to Buy From Neutral, Adjusts PT to $28 From $10

MT Newswires

5 days ago

Wedbush Raises Price Target on Sutro Biopharma to $22 From $10, Keeps Neutral Rating

MT Newswires

6 days ago

Sutro Biopharma Filles $300 Million Mixed Shelf

MT Newswires

6 days ago

Sutro Biopharma Full Year 2025 Loss Narrows, Revenue Grows

Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights

GlobeNewswire

6 days ago

Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights

📈

AI Sentiment

Highly Positive

8/10

Share this news page

Share on Social Networks: